2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   5

Issue No. :  1

Year :  2012

Pages :   75-78

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

Formulation and Evaluation of Metoprolol Succinate Extended Release Tablet

Address:   Jitendra Kumar Putikam1*, Y. Narasimha Rao2, V. Anjaneyulu2 and Vivek Kumar Undralla2
1Nalanda Institute of Pharmaceutical Sciences, Siddharth Nagar, Kantepudi (P.O), Sattenpalli, Guntur, AP, India
2Vagdevi College of Pharmacy, Gurazala, Guntur, AP, India
Corresponding author
DOI No: Not Available

The aim of the present study was to develop an extended release formulation of Metoprolol Succinate to maintain constant therapeutic levels of the drug for over 24 hrs. An efficient extended release formulation of Metoprolol Succninate could be designed as extended release Matrix tablet. The optimized formulation (B-8) was developed by using HPMC [Benecel K35M] and HEC [Natrosol 250HHX] Regulated drug release in first order manner was attained by using these polymers. This extended release formulation (B-8) was found similar and comparable to the innovator product. The developed extended release formulation was quite stable with regard to physical properties and dissolution rate in the accelerated stability studies.
Metoprolol Succinate, Aerosil, Ethocel, Rotary tablet Machine.
Jitendra Kumar Putikam, Y. Narasimha Rao, V. Anjaneyulu, Vivek Kumar Undralla. Formulation and Evaluation of Metoprolol Succinate Extended Release Tablet. Research J. Pharm. and Tech. 5(1): Jan. 2012; Page 75-78.
[View HTML]      [View PDF]

Visitor's No. :   660363